4//SEC Filing
Usdan Adam 4
Accession 0000947871-11-000369
CIK 0001053369other
Filed
Apr 3, 8:00 PM ET
Accepted
Apr 4, 2:11 PM ET
Size
12.8 KB
Accession
0000947871-11-000369
Insider Transaction Report
Form 4
TRELLUS PARTNERS II LP
10% Owner
Transactions
- Sale
Common Stock
2011-03-31$0.08/sh−36,000$3,024→ 21,371,379 total(indirect: See Footnotes)
Trellus Offshore Fund Ltd
10% Owner
Transactions
- Sale
Common Stock
2011-03-31$0.08/sh−36,000$3,024→ 21,371,379 total(indirect: See Footnotes)
TRELLUS PARTNERS LP
10% Owner
Transactions
- Sale
Common Stock
2011-03-31$0.08/sh−36,000$3,024→ 21,371,379 total(indirect: See Footnotes)
Trellus Management Company, LLC
10% Owner
Transactions
- Sale
Common Stock
2011-03-31$0.08/sh−36,000$3,024→ 21,371,379 total(indirect: See Footnotes)
Usdan Adam
10% Owner
Transactions
- Sale
Common Stock
2011-03-31$0.08/sh−36,000$3,024→ 21,371,379 total(indirect: See Footnotes)
Footnotes (4)
- [F1]On March 31, 2011, Trellus Partners, L.P., a Delaware limited partnership ("TPLP") sold 36,000 shares of Common Stock.
- [F2]On March 31, 2011, following the reported transaction, TPLP owned 10,500,972 shares of Common Stock and held warrants to acquire 3,291,426 shares of Common Stock and Trellus Offshore Fund Limited, a Cayman Islands limited liability company ("TOF") owned 6,002,344 shares of Common Stock and held warrants to acquire 1,377,758 shares of Common Stock and Trellus Partners, L.P. II ("TPLPII") owned 165,000 shares of Common Stock and warrants to acquire 33,879 shares of Common Stock. Trellus Management Company, LLC ("Trellus") and Mr. Usdan each beneficially owned the Common Stock and warrants owned by TPLP and TOF, and TPLPII.
- [F3]Trellus is the investment adviser to TPLP, TOF, and TPLPII. Adam Usdan is the controlling principal and chief investment officer of Trellus. By reason of their investment discretion, Trellus and Mr. Usdan are reported herein as indirect beneficial owners of the securities described in this Form 4.
- [F4]Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein.
Documents
Issuer
ELITE PHARMACEUTICALS INC /DE/
CIK 0001053369
Entity typeother
Related Parties
1- filerCIK 0001459107
Filing Metadata
- Form type
- 4
- Filed
- Apr 3, 8:00 PM ET
- Accepted
- Apr 4, 2:11 PM ET
- Size
- 12.8 KB